Moderna, Inc. (MRNA)
NASDAQ · Healthcare
Moderna, Inc. Operating Income 2016–2025
Moderna, Inc. annual/quarterly operating income history and growth rate from 2016 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Moderna, Inc. operating income for the quarter ending March 31, 2026 was -1.4 B, a 32.19% increase year-over-year.
- Moderna, Inc. operating income for the twelve months ending March 31, 2026 was -3.6 B, a 23.48% decrease year-over-year.
- Moderna, Inc. annual operating income for 2025 was -3.1 B, a 22.08% decrease from 2024.
- Moderna, Inc. annual operating income for 2024 was -3.9 B, a 6.94% decrease from 2023.
- Moderna, Inc. annual operating income for 2023 was -4.2 B, a 145.00% decrease from 2022.
- Moderna, Inc. annual operating income for 2022 was 9.4 B.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Moderna Inc. Operating Income — FAQ
Moderna Inc. (MRNA) operating income over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
What is Moderna Inc.'s operating income?
Moderna Inc. (MRNA) reported operating income of -$3.07B for fiscal 2025.
Where can I see MRNA's operating income history?
The chart and table above show Moderna Inc.'s operating income by year and by quarter, including the growth rate.